Global Pharmaceutical Contract Manufacturing Market Report 2021: Market to Reach $130.2 Billion by 2026 - API/Bulk Drugs Segments is Projected to Account for $81.5 Billion
July 15, 2021 07:23 ET
|
Research and Markets
Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global...
US Healthcare Contract Development and Manufacturing Organization (CDMO) Market Report 2021Focus on Contract Development and Contract Manufacturing
June 10, 2021 05:28 ET
|
Research and Markets
Dublin, June 10, 2021 (GLOBE NEWSWIRE) -- The "US Healthcare CDMO Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The US healthcare CDMO market is estimated to grow...
North American Healthcare Contract Development and Manufacturing Organization Market Report 2021 Featuring AbbVie, Baxter International, Catalent, Pfizer, Thermo Fisher Scientific & Jabil
June 09, 2021 04:58 ET
|
Research and Markets
Dublin, June 09, 2021 (GLOBE NEWSWIRE) -- The "North American Healthcare CDMO Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The North American healthcare CDMO market...
$120+ Billion Pharmaceutical Contract Manufacturing Markets - Global Forecast to 2027
May 26, 2021 05:03 ET
|
Research and Markets
Dublin, May 26, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Contract Manufacturing Market - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering. The pharmaceutical...
Outlook on the Pharmaceuticals Contract Development & Manufacturing Global Market to 2026 - Impact of COVID-19 with Ansoff Analysis
May 19, 2021 04:23 ET
|
Research and Markets
Dublin, May 19, 2021 (GLOBE NEWSWIRE) -- The "Global Pharmaceuticals Contract Development & Manufacturing Market (2021-2026) by Service, End-user, Geography and the Impact of COVID-19 with...
Recro Reports First Quarter 2021 Financial Results
May 06, 2021 16:05 ET
|
Recro Pharma, Inc.
Revenues of $16.8 Million Represent an Increase of 70% Compared to Q4 2020 Revenue Multiple New Business Agreements Signed Facilities Expansion and Enhancements Continue Company to Host Conference...
Recro to Report Financial Results for Fourth Quarter And Year-End 2020 on February 26
February 19, 2021 16:05 ET
|
Recro Pharma, Inc.
MALVERN, Pa., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...
Recro Strengthens Leadership Team With Key Executive and Board Appointments
February 11, 2021 07:00 ET
|
Recro Pharma, Inc.
Company Names CDMO Industry Thought Leader, Jim Miller, to Board of Directors and Selects Ryan D. Lake as Dedicated Chief Financial OfficerRecent Appointments, including CEO David Enloe, Provide...
Leukocare starts operations in the US and opens development laboratories and offices in Boston Metropolitan Area
January 11, 2021 08:00 ET
|
LEUKOCARE AG
MARTINSRIED, Germany and MUNICH, Germany and MILFORD, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Germany-based formulation development specialist Leukocare opens US presence to support local...
Starton Therapeutics Selects Formulation for Continuous Subcutaneous Lenalidomide Delivery System for CLL Treatment
January 11, 2021 07:40 ET
|
Starton Therapeutics, Inc.
PARAMUS, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company powering continuous delivery of approved drugs in...